Brubakk O - Search Results

1

Brubakk O, Myrvang B. Brubakk O, et al. Tidsskr Nor Laegeforen. 2000 Oct 30;120(26):3196. Tidsskr Nor Laegeforen. 2000. PMID: 11109372 Free article. Norwegian. No abstract available.

2

[Should dosing practice in aminoglycosides therapy be changed?].

Bruun JN, Brubakk O. Bruun JN, et al. Among authors: brubakk o. Tidsskr Nor Laegeforen. 1999 Sep 10;119(21):3115. Tidsskr Nor Laegeforen. 1999. PMID: 10522473 Norwegian. No abstract available.

3

[When should macrolides be used in upper respiratory tract infections?].

Brubakk O, Bruun JN. Brubakk O, et al. Tidsskr Nor Laegeforen. 2004 Feb 19;124(4):495-6. Tidsskr Nor Laegeforen. 2004. PMID: 14983197 Free article. Norwegian. No abstract available.

4

[Use of a new antibiotic in Norway].

Brubakk O, Bjørneklett A, Sjursen H, Viggen B. Brubakk O, et al. Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1931-2. Tidsskr Nor Laegeforen. 2007. PMID: 17700733 Free article. Norwegian. No abstract available.

5

[Non-typhoid Salmonella aortitis].

Brubakk O, Bruun JN. Brubakk O, et al. Tidsskr Nor Laegeforen. 1993 Feb 10;113(4):457-8. Tidsskr Nor Laegeforen. 1993. PMID: 8465288 Norwegian.

6

[Antibiotic prevention of bacterial endocarditis].

Brubakk O, Bruun JN, Hovig B, Andrew M, Eskerud J, Skoglund LA. Brubakk O, et al. Tidsskr Nor Laegeforen. 1992 Feb 10;112(4):466-71. Tidsskr Nor Laegeforen. 1992. PMID: 1553692 Review. Norwegian.

7

Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety.

Kalager T, Andersen BM, Bergan T, Brubakk O, Bruun JN, Døskeland B, Hellum KB, Hopen G, von der Lippe E, Rahm V, et al. Kalager T, et al. Among authors: brubakk o. Scand J Infect Dis. 1992;24(5):637-46. doi: 10.3109/00365549209054651. Scand J Infect Dis. 1992. PMID: 1465583 Clinical Trial.

8

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.

Wolbers M, Babiker A, Sabin C, Young J, Dorrucci M, Chêne G, Mussini C, Porter K, Bucher HC; CASCADE Collaboration Members. Wolbers M, et al. PLoS Med. 2010 Feb 23;7(2):e1000239. doi: 10.1371/journal.pmed.1000239. PLoS Med. 2010. PMID: 20186270 Free PMC article.

9

Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals.

Mussini C, Cossarizza A, Sabin C, Babiker A, De Luca A, Bucher HC, Fisher M, Rezza G, Porter K, Dorrucci M; CASCADE Collaboration. Mussini C, et al. AIDS. 2011 May 15;25(8):1041-9. doi: 10.1097/QAD.0b013e3283463ec5. AIDS. 2011. PMID: 21412128

10

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.

Touloumi G, Pantazis N, Stirnadel HA, Walker AS, Boufassa F, Vanhems P, Porter K; CASCADE Collaboration. Touloumi G, et al. J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):492-8. doi: 10.1097/QAI.0b013e318186ead2. J Acquir Immune Defic Syndr. 2008. PMID: 18989233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page